Weight Loss Drugs Cause Rebound Effect

Weight Loss Drugs Cause Rebound Effect
Ozempic medication box by David Trinks is licensed under Unsplash unsplash.com

The promise of effortless weight loss through injection may be crashing into reality.  A comprehensive new study published in BMC Medicine has uncovered a troubling pattern: patients who stop taking popular weight loss drugs experience significant weight rebound within just eight weeks of discontinuation.

The meta-analysis examined data from 11 randomized trials involving over 2,400 participants across multiple countries. Researchers tracked what happened when people stopped taking anti-obesity medications (AOMs), including the widely prescribed GLP-1 drugs, such as semaglutide (Ozempic, Wegovy) and tirzepatide.

The results paint a concerning picture of dependency and metabolic disruption that pharmaceutical companies haven’t been eager to discuss.

Researchers discovered a predictable pattern of weight regain that begins almost immediately after stopping these medications.  At four weeks post-discontinuation, patients still maintained some weight loss.  However, by eight weeks, significant weight regain had begun, continuing for an average of 20 weeks before stabilizing.

Medical Disclaimer: This article is for informational and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional regarding your individual health needs.

Ozempic medication box by David Trinks is licensed under Unsplash unsplash.com
ad-image
Copyright © 2026 Feel Amazing Daily - All Rights Reserved
Privacy Policy
Powered by